<DOC>
	<DOCNO>NCT00569764</DOCNO>
	<brief_summary>To measure long-term change weight plasma lipid switch antipsychotic treatment aripiprazole</brief_summary>
	<brief_title>Effect Metabolic Parameters Abilify SPR</brief_title>
	<detailed_description>To measure long-term change weight , plasma lipid fast blood glucose switch antipsychotic treatment aripiprazole , 1 year , open label study in-patients schizophrenia . The measurement weight lipid profile fast blood glucose measure baseline every 3 month 1 year .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>DSMIV diagnosis schizophrenia sign informed consent comorbid substance abuse substance dependence pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>aripiprazole</keyword>
</DOC>